Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 42444626.
- Also identified by DOI 10.1192/bjp.2026.10729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this editorial, I examine the parallels between conventional and assisted suicide. Psychedelic therapy has been shown to alleviate end-of-life distress and reduce suicidality. I advocate for rescheduling psychedelics to enable research into their effectiveness as an adjunct to palliative care, prior to institutionalising assisted suicide in the UK.